| 1 |
33152664 | Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy. | 2021 Jan |
1 |
| 2 |
18413793 | Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. | 2008 Apr |
1 |
| 3 |
17673571 | 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase. | 2007 Nov |
1 |
| 4 |
16455452 | A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth. | 2006 Feb |
1 |
| 5 |
16497409 | Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells. | 2006 Apr |
1 |
| 6 |
16887935 | Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor. | 2006 Nov |
1 |
| 7 |
16060857 | Neutrophil gelatinase-associated lipocalin as a survival factor. | 2005 Oct 15 |
2 |
| 8 |
14973075 | 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells. | 2004 Feb 15 |
2 |
| 9 |
15205346 | From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. | 2004 Jun 15 |
9 |
| 10 |
12000750 | Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. | 2002 Aug 2 |
7 |